Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |